# A Study to Assess the Bioequivalence Between Brivaracetam Tablet and Dry Syrup in Healthy Japanese Male Study Participants

> **NCT06312566** · PHASE1 · COMPLETED · sponsor: **UCB Biopharma SRL** · enrollment: 64 (actual)

## Conditions studied

- Healthy Study Participants

## Interventions

- **DRUG:** brivaracetam (BRV) tablet
- **DRUG:** brivaracetam (BRV) dry syrup

## Key facts

- **NCT ID:** NCT06312566
- **Lead sponsor:** UCB Biopharma SRL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-25
- **Primary completion:** 2024-06-04
- **Final completion:** 2024-06-04
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2025-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06312566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06312566, "A Study to Assess the Bioequivalence Between Brivaracetam Tablet and Dry Syrup in Healthy Japanese Male Study Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06312566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*